Results 11 to 20 of about 66,203 (260)
HIV-1 Latency in Monocytes/Macrophages [PDF]
Human immunodeficiency virus type 1 (HIV-1) targets CD4+ T cells and cells of the monocyte/macrophage lineage. HIV pathogenesis is characterized by the depletion of T lymphocytes and by the presence of a population of cells in which latency has been ...
Wasim Abbas, Georges Herbein
exaly +6 more sources
Latency: the hidden HIV-1 challenge [PDF]
Eradication of HIV-1 from an infected individual cannot be achieved by current regimens. Viral reservoirs established early during the infection remain unaffected by anti-retroviral therapy for a long time and are able to replenish systemic infection ...
Marcello Alessandro
doaj +4 more sources
Post-Transcriptional HIV-1 Latency: A Promising Target for Therapy? [PDF]
Human Immunodeficiency Virus type 1 (HIV-1) latency represents a significant hurdle in finding a cure for HIV-1 infections, despite tireless research efforts.
Mie Kobayashi-Ishihara +1 more
doaj +3 more sources
HIV-1 Latency and Latency Reversal: Does Subtype Matter? [PDF]
Cells that are latently infected with HIV-1 preclude an HIV-1 cure, as antiretroviral therapy does not target this latent population. HIV-1 is highly genetically diverse, with over 10 subtypes and numerous recombinant forms circulating worldwide.
Indra Sarabia, Alberto Bosque
exaly +4 more sources
NSC95397 Is a Novel HIV-1 Latency-Reversing Agent. [PDF]
The latent viral reservoir represents one of the major barriers to curing HIV-1. Focus on the kick and kill (also called shock and kill) approach, in which virus expression is reactivated, and then cells producing virus are selectively depleted, has led ...
Nichols Doyle R +5 more
europepmc +8 more sources
Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency [PDF]
info:eu-repo/semantics ...
Alexander O. Pasternak +4 more
doaj +7 more sources
A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency [PDF]
To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1 infected pseudohaploid KBM7 cell line (Hap-Lat).
Michael Röling +13 more
doaj +2 more sources
Molecular Understanding of HIV-1 Latency [PDF]
The introduction of highly active antiretroviral therapy (HAART) has been an important breakthrough in the treatment of HIV-1 infection and has also a powerful tool to upset the equilibrium of viral production and HIV-1 pathogenesis.
W. Abbas, G. Herbein
doaj +4 more sources
BRD9 functions as an HIV-1 latency regulatory factor. [PDF]
A major challenge for HIV type 1 (HIV-1) cure is the presence of viral latent reservoirs. The “Shock & Kill” strategy involves the combined use of latency reversal agents (LRA) and antiretroviral treatment (ART) to reactivate HIV-1 latent reservoirs ...
Luk TY +14 more
europepmc +2 more sources
Modulation of IRF7-driven transcription as a strategy to control HIV-1 latency [PDF]
BackgroundThe persistence of latent HIV-1 reservoirs remains a major barrier to achieving a cure for HIV. While latency-reversing agents (LRAs) have been extensively studied, latency-promoting agents (LPAs) offer a complementary strategy to silence viral
Ifeanyi Jude Ezeonwumelu +19 more
doaj +2 more sources

